New Key Statistics Module, Z-Score and F-Score
TSX:MBX Key Ratios
Market Cap C$ M | 48.53 |
Enterprise Value C$ M | 42.08 |
P/E(ttm) | 9.34 |
PE Ratio without NRI | 15.43 |
Forward PE Ratio | 17.75 |
Price/Book | 1.73 |
Price/Sales | 2.10 |
Price/Free Cash Flow | 177.50 |
Price/Owner Earnings | 16.90 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 23.00 |
EPS (TTM) C$ | 0.04 |
Beneish M-Score | -1.37 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 7.02 |
EV-to-EBITDA | 5.60 |
PEG | -- |
Shares Outstanding M | 136.70 |
Net Margin (%) | 21.73 |
Operating Margin % | 9.43 |
Pre-tax Margin (%) | 21.73 |
Quick Ratio | 4.89 |
Current Ratio | 6.62 |
ROA % (ttm) | 13.92 |
ROE % (ttm) | 19.49 |
ROIC % (ttm) | 10.13 |
Dividend Yield % | -- |
Altman Z-Score | 3.53 |
TSX:MBX Number of Guru Trades
TSX:MBX Volume of Guru Trades
Gurus Latest Trades with TSX:MBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:MBX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Microbix Biosystems Inc Insider Transactions
No Available Data